---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-049874"
form_type: "8-K"
ticker: "LPCN"
cik: "0001535955"
company_name: "Lipocine Inc."
filed_at: "2024-12-13T23:59:59+00:00"
generated_at: "2026-05-29T03:35:04.745389+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.05
calibrated_materiality_score: 0.05
confidence: "low"
source: SEC EDGAR
---

# Lipocinc updates corporate presentation for investor meetings

## Summary
- Company filed an updated corporate presentation as Exhibit 99.1 to 8-K.
- Presentation is used in meetings with investors, analysts, and other stakeholders.
- No specific financial or operational changes were disclosed in the filing.

## SEC filing metadata
- accession: 0001493152-24-049874
- form_type: 8-K
- ticker: LPCN
- cik: 0001535955
- company_name: Lipocine Inc.
- filed_at: 2024-12-13T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.05
- calibrated_materiality_score: 0.05
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1535955/000149315224049874/0001493152-24-049874-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1535955/000149315224049874/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-049874
- JSON: https://secwatch.observer/filing/0001493152-24-049874.json
- Plain text: https://secwatch.observer/filing/0001493152-24-049874.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.